Insigma Technology Co., Ltd. (SHA:600797)
China
· Delayed Price · Currency is CNY 8.82
+0.14 (1.61%)
Apr 29, 2026, 3:00 PM CST
Insigma Technology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 3,278 | 3,273 | 3,566 | 4,077 | 4,172 | Upgrade
|
| Other Revenue | - | 41.97 | 33.96 | 52 | 73.25 | Upgrade
|
| Revenue | 3,278 | 3,315 | 3,600 | 4,129 | 4,246 | Upgrade
|
| Revenue Growth (YoY) | -1.14% | -7.90% | -12.83% | -2.73% | 11.60% | Upgrade
|
| Cost of Revenue | 2,646 | 2,629 | 2,775 | 3,132 | 3,204 | Upgrade
|
| Gross Profit | 631.55 | 686.63 | 824.36 | 997.95 | 1,041 | Upgrade
|
| Selling, General & Admin | 431.76 | 477.19 | 515.91 | 542.94 | 576.59 | Upgrade
|
| Research & Development | 175.46 | 226.13 | 287.93 | 326.41 | 352.48 | Upgrade
|
| Other Operating Expenses | 5.15 | 16.69 | 13.99 | 16.61 | 13.51 | Upgrade
|
| Operating Expenses | 612.36 | 739.53 | 825.33 | 923.6 | 971.95 | Upgrade
|
| Operating Income | 19.19 | -52.89 | -0.97 | 74.35 | 69.24 | Upgrade
|
| Interest Expense | - | -39.46 | -30.82 | -48.38 | -64.89 | Upgrade
|
| Interest & Investment Income | 17.53 | 28.87 | 36.54 | 131.8 | 67.95 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 0.98 | 1.76 | 1.65 | -0.46 | Upgrade
|
| Other Non Operating Income (Expenses) | -49.99 | 1.99 | -1.39 | -5.43 | 0.95 | Upgrade
|
| EBT Excluding Unusual Items | -13.27 | -60.52 | 5.12 | 153.99 | 72.8 | Upgrade
|
| Impairment of Goodwill | - | - | - | -6.71 | -624.23 | Upgrade
|
| Gain (Loss) on Sale of Investments | -3.26 | -1.19 | 126.26 | -4.13 | -14.1 | Upgrade
|
| Gain (Loss) on Sale of Assets | 1.34 | -1.07 | -3.29 | 3.39 | -1.44 | Upgrade
|
| Asset Writedown | -2.66 | -19.24 | -2.77 | 0.12 | -39.98 | Upgrade
|
| Other Unusual Items | - | 21.17 | 40.63 | 27.23 | 14.71 | Upgrade
|
| Pretax Income | -17.85 | -60.85 | 165.94 | 173.88 | -592.24 | Upgrade
|
| Income Tax Expense | 23.05 | 10.2 | 31.9 | 19.66 | 22.18 | Upgrade
|
| Earnings From Continuing Operations | -40.89 | -71.05 | 134.04 | 154.22 | -614.42 | Upgrade
|
| Minority Interest in Earnings | -14.36 | 7.51 | -16.29 | -28.97 | -17.15 | Upgrade
|
| Net Income | -55.25 | -63.54 | 117.75 | 125.25 | -631.57 | Upgrade
|
| Net Income to Common | -55.25 | -63.54 | 117.75 | 125.25 | -631.57 | Upgrade
|
| Net Income Growth | - | - | -5.99% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 1,105 | 1,015 | 981 | 963 | 1,019 | Upgrade
|
| Shares Outstanding (Diluted) | 1,105 | 1,015 | 981 | 1,044 | 1,019 | Upgrade
|
| Shares Change (YoY) | 8.85% | 3.45% | -5.99% | 2.46% | 0.37% | Upgrade
|
| EPS (Basic) | -0.05 | -0.06 | 0.12 | 0.13 | -0.62 | Upgrade
|
| EPS (Diluted) | -0.05 | -0.06 | 0.12 | 0.12 | -0.62 | Upgrade
|
| Free Cash Flow | 372.34 | 13.39 | 112.56 | -49.95 | 44.72 | Upgrade
|
| Free Cash Flow Per Share | 0.34 | 0.01 | 0.12 | -0.05 | 0.04 | Upgrade
|
| Dividend Per Share | - | - | 0.040 | 0.030 | - | Upgrade
|
| Dividend Growth | - | - | 33.33% | - | - | Upgrade
|
| Gross Margin | 19.27% | 20.71% | 22.90% | 24.17% | 24.52% | Upgrade
|
| Operating Margin | 0.58% | -1.59% | -0.03% | 1.80% | 1.63% | Upgrade
|
| Profit Margin | -1.69% | -1.92% | 3.27% | 3.03% | -14.88% | Upgrade
|
| Free Cash Flow Margin | 11.36% | 0.40% | 3.13% | -1.21% | 1.05% | Upgrade
|
| EBITDA | 210.91 | 122.72 | 223.29 | 333.37 | 259.02 | Upgrade
|
| EBITDA Margin | 6.43% | 3.70% | 6.20% | 8.07% | 6.10% | Upgrade
|
| D&A For EBITDA | 191.72 | 175.61 | 224.27 | 259.02 | 189.78 | Upgrade
|
| EBIT | 19.19 | -52.89 | -0.97 | 74.35 | 69.24 | Upgrade
|
| EBIT Margin | 0.58% | -1.59% | -0.03% | 1.80% | 1.63% | Upgrade
|
| Effective Tax Rate | - | - | 19.22% | 11.31% | - | Upgrade
|
| Revenue as Reported | - | 3,315 | 3,600 | 4,129 | 4,246 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.